Quick answers
- What is Retrovir?
- Retrovir is a brand name of Zidovudine, a prescription medicine. The FDA NDC Directory lists 3 Retrovir products in 3 strengths and forms.
- Who makes Retrovir?
- Viiv Hlthcare holds the FDA application for Retrovir (NDA019655, approved March 19, 1987).
- Is there a generic or store brand of Retrovir?
- Yes. The FDA NDC Directory lists 1 other product with the same active ingredients, strength and form as a Retrovir product, 1 of them generic. Ask your pharmacist whether one is right for you.
- Has Retrovir been recalled?
- No recall linked to Retrovir products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Retrovir is
Each Retrovir product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Zidovudine · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| zidovudine 10 mg/mL injection, solution (intravenous) | Retrovir | None listed | — |
| zidovudine 10 mg/mL solution (oral) | Retrovir | None listed | — |
| zidovudine 100 mg capsule (oral) | Retrovir | 1 product, 1 company | — |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Zidovudine →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
Companies that list Retrovir
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Retrovir products.
- ViiV Healthcare Company3 products
Recalls
No recall linked to Retrovir products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.